Toronto, Canada--Khiron Life Sciences Corp. announced in a news release that Zerenia has signed a contract with insurance CAPITAL SALUD EPS, to provide medical cannabis services and products to CAPITAL SALUD EPS patient population, which and has already begun treating the first cohort of patients.
The release noted that under the contract, CAPITAL SALUD EPS patients will get access to Khiron's products and clinical services fully reimbursed by CAPITAL SALUD EPS.
In 2022, the Bogota City Council and the Bogota Mayor's office launched a first-of-its-kind initiative to establish the city as a research, production, and commercialization hub for medical cannabis for Colombia and Latin America. As part of this initiative, CAPITAL SALUD EPS — wholly owned by the City of Bogota — has signed a contract with Zerenia to provide "Integrative Health Services and Pharmacotherapeutic Treatment with Medical Cannabis" to its patient population.
"This agreement by CAPITAL SALUD EPS seeks the materialization of Agreement 831 that we promoted at the Bogota City Council, with the objective of making Bogota the medical cannabis hub of the country," City councilman Juan Baena, who spearheaded the initiative, commented, as per the release.
Under the contract with CAPITAL SALUD EPS, Zerenia will provide integrative health services and medical cannabis products to patients diagnosed with chronic pain, mental health, neurological conditions, and epilepsy, amongst others. With an annual budget of more than CAD 500 million, 1.2 million insured individuals, and more than 280,000 patients diagnosed with chronic conditions, CAPITAL SALUD EPS is the largest public insurance company in Colombia.
Learn more about the contract in the entire release.